Pursue Wealth Partners LLC Grows Position in Axon Enterprise, Inc $AXON

Pursue Wealth Partners LLC lifted its position in shares of Axon Enterprise, Inc (NASDAQ:AXON) by 27.4% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The firm owned 3,910 shares of the biotechnology company’s stock after purchasing an additional 842 shares during the quarter. Axon Enterprise accounts for approximately 1.2% of Pursue Wealth Partners LLC’s portfolio, making the stock its 29th largest holding. Pursue Wealth Partners LLC’s holdings in Axon Enterprise were worth $2,192,000 at the end of the most recent reporting period.

Other institutional investors have also recently made changes to their positions in the company. Creative Financial Designs Inc. ADV acquired a new position in shares of Axon Enterprise in the fourth quarter worth about $28,000. Camelot Portfolios LLC purchased a new position in shares of Axon Enterprise in the 4th quarter valued at about $30,000. AlphaCentric Advisors LLC purchased a new position in shares of Axon Enterprise in the 4th quarter valued at about $34,000. Darwin Wealth Management LLC acquired a new position in Axon Enterprise in the 2nd quarter worth about $37,000. Finally, Strive Financial Group LLC purchased a new position in Axon Enterprise during the fourth quarter worth approximately $41,000. 79.08% of the stock is owned by hedge funds and other institutional investors.

Analyst Ratings Changes

A number of research firms have recently commented on AXON. Zacks Research cut Axon Enterprise from a “strong-buy” rating to a “hold” rating in a research report on Friday, July 10th. Needham & Company LLC reissued a “buy” rating on shares of Axon Enterprise in a research note on Thursday, August 6th. JPMorgan Chase & Co. boosted their price target on shares of Axon Enterprise from $750.00 to $755.00 and gave the stock an “overweight” rating in a report on Thursday, May 7th. Royal Bank Of Canada restated an “outperform” rating on shares of Axon Enterprise in a research report on Tuesday, July 21st. Finally, Barclays increased their price objective on shares of Axon Enterprise from $523.00 to $688.00 and gave the company an “overweight” rating in a report on Thursday, August 6th. Thirteen research analysts have rated the stock with a Buy rating and three have issued a Hold rating to the company’s stock. Based on data from MarketBeat, Axon Enterprise has a consensus rating of “Moderate Buy” and a consensus target price of $730.92.

Axon Enterprise Stock Performance

Shares of AXON stock opened at $604.32 on Tuesday. The stock’s 50-day moving average is $528.72 and its two-hundred day moving average is $473.44. The firm has a market cap of $49.09 billion, a price-to-earnings ratio of 250.76, a PEG ratio of 9.95 and a beta of 1.39. Axon Enterprise, Inc has a 1 year low of $339.01 and a 1 year high of $794.29. The company has a debt-to-equity ratio of 0.47, a quick ratio of 1.80 and a current ratio of 2.15.

Axon Enterprise (NASDAQ:AXON) last posted its earnings results on Tuesday, August 4th. The biotechnology company reported $1.88 earnings per share for the quarter, beating the consensus estimate of $1.84 by $0.04. The business had revenue of $904.39 million during the quarter, compared to the consensus estimate of $876.42 million. Axon Enterprise had a return on equity of 2.84% and a net margin of 6.19%.The business’s quarterly revenue was up 35.3% on a year-over-year basis. During the same period in the previous year, the business earned $2.12 EPS. Analysts predict that Axon Enterprise, Inc will post 2.04 earnings per share for the current year.

Insider Activity at Axon Enterprise

In other Axon Enterprise news, CEO Patrick W. Smith sold 20,000 shares of Axon Enterprise stock in a transaction that occurred on Thursday, June 4th. The stock was sold at an average price of $500.00, for a total transaction of $10,000,000.00. Following the transaction, the chief executive officer owned 3,060,997 shares of the company’s stock, valued at $1,530,498,500. The trade was a 0.65% decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available at this hyperlink. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, insider Elizabeth Reid Coughlin sold 1,554 shares of the business’s stock in a transaction that occurred on Thursday, June 4th. The shares were sold at an average price of $485.00, for a total value of $753,690.00. Following the completion of the sale, the insider owned 34,024 shares of the company’s stock, valued at approximately $16,501,640. This represents a 4.37% decrease in their position. The SEC filing for this sale provides additional information. Insiders have sold a total of 68,989 shares of company stock valued at $36,016,932 over the last 90 days. 4.20% of the stock is owned by insiders.

Axon Enterprise Profile

Axon Enterprise, Inc develops technology and weapons systems for public safety and law enforcement agencies, combining hardware, software and cloud services. The company’s hardware portfolio includes conducted energy weapons (commonly known as TASER devices), body-worn cameras and in-car camera systems. Axon pairs these devices with a suite of connected products and accessories designed to capture, store and manage field evidence.

Beyond hardware, Axon operates a subscription-based software platform for digital evidence management, evidence review and records management.